Early major ischemic changes on computed tomography should preclude use of tissue plasminogen activator.
von Kummer
Rudiger
R
Department of Neuroradiology, University of Technology, Dresden, Germany. kummer-r@rcs.urz.tu-dresden.de
D001921:Brain / Q000098:blood supply* / Q000000981:diagnostic imaging*; D001929:Brain Edema / Q000000981:diagnostic imaging / Q000209:etiology; D002545:Brain Ischemia / Q000150:complications / Q000000981:diagnostic imaging* / Q000188:drug therapy; D000075202:Contraindications; D018450:Disease Progression; D006801:Humans; D011237:Predictive Value of Tests; D020127:Recovery of Function / Q000187:drug effects; D018570:Risk Assessment; D012307:Risk Factors; D013997:Time Factors; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use; D014057:Tomography, X-Ray Computed
D010959:Tissue Plasminogen Activator